Living Well Through Cancer Treatment and Beyond

Issue link:

Contents of this Issue


Page 29 of 31

Contributing to the future 30 Patients who volunteer for clinical trials not only gain access to experimental treatments – they also help future patients by contributing to important advancements in medical care. Through their participation in clinical trials, Providence patients have contributed to: • FDA approval of the first engineered antibody to treat patients with advanced melanoma – a drug that was the first to increase survival for people with this deadly cancer, ushering in the modern age of immunotherapy • The first FDA-approved immunotherapy treatment for lung cancer • New treatment approaches for brain tumors, breast cancer, kidney cancer, pancreatic cancer, oral, head and neck cancers, and many other types of cancer Heroes? Each and every one of them. To all of our patients, past and present: You have our deepest gratitude. If you'd like to know more about studies that may be appropriate for you, please ask your health care team. Learn more about our clinical trials at

Articles in this issue

Links on this page

Archives of this issue

view archives of Guides - Living Well Through Cancer Treatment and Beyond